StockData

Cabot Corp (CBT) stock analysis

CBTNYSEMiscellaneous Chemical ProductsFiscal year ends September 30
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 19/3047% below fair value
$72.23+0.04 (+0.06%)

Close on Nov 11, 2026Market cap $3.73BP/E 13.3Yield 2.44%

StockData Score

Prices as of Nov 11, 2026How the score works

Value4Growth2Performance4Health5Dividend4

Solid19 of 30 checks passed

Cabot passes 19 of the 30 checks behind our score; 2 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
4/6
Growth
2/6
Past performance
4/6
Financial health
5/6
Dividend
4/6

What stands out

  • Margin of safety over 20%

    The price is 47.4% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $72.23 is below our fair value estimate of $137.19.

  • Return on equity over 15%

    Return on equity was 19.2% over the last twelve months and averaged 29.0% over five years.

  • Return on capital over 10%

    Return on invested capital was 15.1%, above the 10% that usually covers the cost of capital.

What to watch

  • High debt

    Debt is 79.3% of shareholders' equity, above the 40% we consider low.

  • Revenue growing under 10% a year

    Revenue grew -4.9% a year over the last three fiscal years, short of the 10% we look for.

  • P/E above its 5-year median

    Cabot's P/E of 13.3 is above its own 5-year median of 12.9.

  • Guidance lowered

    Cabot lowered its full year Adjusted EPS outlook on Feb 3, 2026.

Valuation4/6
  • P/E above its 5-year median

    Cabot's P/E of 13.3 is above its own 5-year median of 12.9.

  • P/E below the industry

    Cabot's P/E of 13.3 is below the Chemicals and Allied Products median of 25.2.

  • EV/EBITDA below its 5-year median

    Cabot's EV/EBITDA of 5.6 is below its 5-year median of 7.7.

  • P/B above the industry

    Cabot's price-to-book of 2.32 is above the Chemicals and Allied Products median of 2.24.

  • Trading below fair value

    The share price of $72.23 is below our fair value estimate of $137.19.

  • Margin of safety over 20%

    The price is 47.4% below fair value, more than the 20% cushion we look for.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew -4.9% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing 10%+ a year

    Diluted EPS grew 18.5% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 16.6% over the last twelve months; the Chemicals and Allied Products median is 11.0%.

  • Guidance lowered

    Cabot lowered its full year Adjusted EPS outlook on Feb 3, 2026.

  • Gross margin slipping

    Gross margin was 23.5% over the last twelve months, against 24.9% a year earlier.

Past performance4/6
  • Return on equity over 15%

    Return on equity was 19.2% over the last twelve months and averaged 29.0% over five years.

  • Return on capital over 10%

    Return on invested capital was 15.1%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Cabot's return on equity of 19.2% is above the Chemicals and Allied Products median of 7.4%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin below its 5-year average

    Net margin was 6.4% over the last twelve months, against a 5-year average of 8.4%.

  • Net margin above the industry

    Cabot's net margin of 6.4% is above the Chemicals and Allied Products median of 5.6%.

Financial health5/6
  • High debt

    Debt is 79.3% of shareholders' equity, above the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 161% five years ago to 79.3%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 58.6% of total debt.

  • Interest well covered

    Operating income covers interest expense 7.1 times.

  • Short-term assets cover short-term debts

    Current assets are 1.47 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 3.49; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    Cabot paid dividends worth 2.6% of the share price over the last twelve months.

  • Yield below Treasuries

    The 2.6% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Cabot yields 2.6%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 41.6% of net income.

  • Covered by free cash flow

    Dividends take 25.8% of free cash flow.

Scores of similar companies

Our estimate per share

$137.19

The share price is 47% below this estimate.

20%+ below
Near fair value
20%+ above
$72.23Price$137.19Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E19.0×12.9×25.2×$103.1040%
EV/EBITDA13.2×7.7×18.8×$205.2435%
P/B2.9×3.5×2.2×$88.9210%
Earnings power9.6% cost of equity––$101.5215%
Fair value$137.19100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 12.9
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$29.89M
Value traded per 1% price move
$25.82M

Downside

Low risk

Typical loss in a bad month
9.5%
Volatility (annualized)
32%
Sharpe ratio, 1 year
0.43
Beta to the S&P 500 (5Y)
0.94

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

25.3%+6.2 pts over 5 years

Operating margin

16.7%+15.9 pts over 5 years

Net margin

8.9%+18.0 pts over 5 years

See a number that looks wrong?